28. Ghika J, Tennis M, Hoffman E, et al: Idazoxan treatment in
progressive supranuclear palsy. Neurology 41:986, 1991
29. Gibb WRG, Lees AJ: Anatomy, pigmentation, ventral and dorsal
subpopulations of the substantia nigra, and differential cell death
in Parkinson's disease. j Neurol Neurosurg Psych 54:388, 1991
30. Gibb WRG, Luthert PJ, Janota I. Lantos PL: Cortical Lewy body
dementia: Clinical features and classification. J Neurol Neurosurg
Psych 52:185, 1989
31. Gibb WRG, Luthert PJ, Marsden CD: Clinical and pathological features
of corticobasal degeneration. Adv Neurol 53:51, 1990
32. Gibb WRG, Mountjoy CQ, Mann DMA. Lees AJ: The substantia nigra and
ventral tegmental area in Alzheimer's disease and Down's syndrome
J Neurol Neumsurg Psych 52:193, 1989
33. Gibb WRG, Scott T, Lees AJ: Neuronal inclusions of Parkinson's
disease. Mov Disorders 6:2, 1991
34. Gilaldi N, Burke RE, Kostic V, et al: Hemiparkinsonism-hemiatrophy
syndrome. Neurology 40:1731, 1990
35. Gilbert JJ, Kish SJ, Chang L-J, et al: Dementia, parkinsonism and
motor neuron disease: Neurochemical and neuropathological correlates.
Ann Neurol 24:688, 1988
36. Gilman S, Markel DS, Koeppe RA, et al: Cerebellar and brainstem
hypometabolism in olivupontocerebellar atrophy with positron emission
tomography. Ann Neurol 23:223, 1988
37. Goffinet AM, De VoIder AG, Gillian C, et al: Positron tomography
demonstrates frontal lobe hypometabolism in progressive supranuclear
palsy. Ann Neurol 25:131, 1989
38. Goldstein DS. Polinsky RJ, Garty M, et al: Patterns of plasma levels
of catechols in neurogenic orthostatic hypotension. Ann Neurol
26:558, 1989
39. Goto S, Hirano A. Matsumoto S: Immunohistochemical study of the
striatal efferents and nigral dopaminergic neurons in parkinsonism-
dementia complex on Guam in comparison with those in Parkinson's
and Alzheimer's disease. Ann Neurol 27:520, 1990
40. Goto S, Hirano A, Matsumoto S: Met-enkephalin immunoreactivity in the
basal ganglia in Parkinson's disease and striatonigraI degeneration.
Neurology 40:1051, 1990
41. Grafman J, Litvan I, Gomez C, Chase T: Frontal lobe function in
progressive supranuclear palsy. Arch Neurol 47:553, 1990
42. Graham JG, Oppenheimer DR: Orthostatic hypotension and nicotinic
sensitivity in a case of multiple system atmphy. I Neurol Neurosurg
Psych 32:28, 1969
43. Gray F, Vincent D, Hauw JJ: Quantitative study of lateral horn cells
in 15 cases of multiple system atrophy. Acta Neuropath 75:513, 1988
44. Hirano A, Kurland LT, Krooth RS, Lessell LS: Parkinsonism-dementia
complex, and endemic disease on the island of Guam. Clinical features.
11. Pathologic features. Brain 84:642, 1961
45. Ishino H, Higashi H, Kuroda S, et al: Motor nuclear involvement in
progressive supranuclear palsy. J Neurol Sci 22:235, 1973
46. Jankovic J: Controlled trial of pergolide mesylate in Parkinson's
disease and progressive supranuclear palsy. Neurology 33:505, 1983
47. Jankovic J: Apraxia of eyelid opening in progressive supranuclear
palsy. Ann Neurol 15:115, 1984
48. Jankovic J: Progressive supranuclear palsy: Clinical and
pharmacologic update. Neurol Clin 2:473, 1984
49. Jankovic J: Parkinson's plus syndromes. Mov Disorders 4:595, 1989
50. Jankovic J: The relationship between Parkinson's disease and other
movement disorders. In CaIne DB (ed): Handbook of Experimental
Pharmacology, Vol 88. Berlin, Springer-Verlag, 1989, p 227
51. Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N EngI
J Med 324:1186, 1991
52. Jankovic J, Friedman DI, Pirozzolo FJ, McCrary JA: Progressive
supranuclear palsy: Motor, neurobehavioral, and neuro-ophthalmic
findings. Adv Neurol 53:293, 1990
53. Jankovic J,Bilden JL, Hiner BC, et al: Neurogenic orthostatic
hypotension: A doubleblind placebo-controlled study with midodrine.
Neurology 41(suppl 1):284, 1991
54. Jankovic J, McDermott M, Carter J, et al: Variable expression of
Parkinson's disease: A baseline analysis of the DATATOP' cohort.
Neurology 40:1529. 1990
55. Joachim CL, Morris JII, Kosik KS, Seldoe DJ: Tau antisera recognize
neurofibrillary tangles in a range of neurodegenerative disorders.
Ann Neurol 18:523, 1985
56. Jume A, Takashi A. Hashizume Y, Asai J: A histometrical and
comparative study on Purkinje cell loss and olivary nucleus cell loss
in multiple system atrophy. J Neurol Neurosci 101:178, 1991
57. Juncos JL, Hirsch EC. Malessa S, et al: Mesencephalic cholinergic
nuclei in progressive supranuclear palsy. Neurology 41:25, 1990
58. Kato S, Nakamura H: Cytoplasmic argyophilic inclusions in neurons of
pontine nuclei in patients with olivopontocerebellar atrophy:
Immunohistochemical and ultrastructural studies. Acta Neuropath
(Berlin) 79:584, 1990
59. Kaye JA, May C, Daly E, et al: Cerebrospinal fluid monoamine markers
are decreased in dementia of the Alzheimer type with extrapyramidal
features. Ann Neurol 38:554. 1988
60. Kertzman C, Robinson DL, Litvan I: Effects of physostigmine on spatial
attention in patients with progressive supranuclear palsy. Arch
Neuml 47:1346, 1990
61. Kish SJ, Du F, Parks DA, et al: Quinolinic acid catabolism is
increased in cerebellum of patients with dominantly inherited
olivopontocerebellar atrophy. Ann Neurol 29:100, 1991
62. Koeppen AH, Mitzen EJ, Hans MC, Barron KD: Olivopontocerebellar
atrophy; immunocytochemical and Golgi observations. Neumlogy
36:1478, 1986
63. Kosaka K, Matsushita R. Oyanagi S, et al: Pallido-nigral-luysial
atrophy with massive appearence of corpora amylacea in the CNS.
Acta Neuropath (Berlin) 53:169, 1981
64. Kosic KS: Alzheimer's plaques and tangles: Advances on both fronts.
Trends Neurosci 14:218, 1991
65. Kostic VS, Mojsilvoc LJ, Stojanovic M: Degenerative neurological
disorders associated with a deficiency of glutamate dehydrogenase.
J Neurol 236:111. 1989
66. Lepore FE. Duvoisin RC: "Apraxia" of eyelid opening: An involuntary
levator inhibition. Neurology 35:423, 1985
67. Lepore FE, Steele JC, Cox TA, et al: Supwnuclear disturbances of
ocular motility in Lytico-Bodig. Neurology 38:1849, 1988
68. Lewis AJ, Gawel MJ: Diffuse Lewy body disease with dementia and
oculomotor dysfunction. Mov Disorders 5:143-147. 1991
69. Lippa CF, Smith TW, Fontneau N: Corticonigral degeneration with
neuronal achromasia. J Neurol Sci 98:301, 1990
70. Litvan I, Grafman J, Gomez C, Chase T: Memory impairment in patients
with progressive supranuclear palsy. Arch Neurol 46:765, 1989
71. Lou JS, Jankovic J: Essential tremor: Clinical correlates in 350
patients. Neurology 41:234, 1991
72. Maher ER, Lees AJ: The clinical features and natural history of Steel-
Richardson-Olszewski (progressive supranuclear palsy). Neurology
36:1005, 1986
73. Makoweic RL, Albin RL, Cha JJ, et al: Two types of quisqualate
receptors are decreased in human olivopontocerebellar atrophy
cerebellar cortex. Brain Res 523:309, 1990
74. Malessa S, Hirsch EC, Cervera P, et al: Catecholamingeric systems in
the medulla oblongata in parkinsonian syndromes. Neurology 40:1739,
1990
75. Matsumoto S, Hirano A, Goto S: Spinal cord neurofibrillary tangle of
Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia
complex. Neurology 40:975, 1990
76. Matsuo H, Takashima H. Kishikawa M, et al: Pure akinesia: An atypical
manifestation of progressive supranuclear palsy. J Neurol
Neurosurg Psych 54:397, 1991
77. Mayeux R, Stern Y. Spanton S: Heterogeneity in dementia of the
Alzheimer's type: Evidence of subgroups. Neurology 35:453, 1985
78. McLeod JO, Tuck RIt: Disorders of the autonomk nervous system: Part 1.
Path',
physiology and dinical features. Ann Neurol 21:419, 1987
79. McLeod JG, Tuck RR: Disorders of the autonomic nervous system:
Part 2. Investigation and treatment. Ann Neurol 21:519. 1987
80. de la Monte SM. Wells SE, Hedley-Whyte ET, Growdon JH:
Neuropathological
distinction between Parkinson's dementia and parkinson's plus
Alzheimer's disease. Ann Neurol 26:309. 1989
81. Munschauer FE. Loh L. Bannister R, Newsom-Davis J: Abnormal
respiration and sudden death during sleep in multiple system atrophy
with autonomic failure. Neurology 40:677. 1990
82. Nakazato Y, Yamazaki HY, Hirato J, et al: Oligodendroglial
microtubular tangles in olivopontocerebellar atrophy. J Neuropath
Exp Neurol 49:521, 1990
83. Newman GC: Treatment of progressive supranuclear palsy with tricyclic
antidepressants. Neurology 35:1189, 1985
84. Nygaard TG. Duvoisin RC. Manocha M. Chokroverty S: Seizures in
progressive supranuclear palsy. Neurology 39:138. 1989
85. O'Brien C, Sung JH, McGeachie RE, Lee MC: 5triatonigral degeneration:
Clinical, MRI, and pathologic correlation. Neurology 40:710, 1990
86. Pakkenberg B, Moller A, Gundersen HJG. et al: The absolute number of
nerve cells in substantia nigra in normal subjects and in patients
with Parkinson's disease estimated with an unbiased stereological
method. J Neurol Neurosurg Psych 54:30. 1991
87. Papp M. Kahn JE. Lantos PL: Glial cytoplasmic inclusions in the CNS
of patients with multiple atrophy (striatonigral degeneration,
olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol
Sci 94:79. 1989
88. Pastakia B. Polinsky R, Di Chiro G, et al: Multiple system atrophy
(Shy-Drager syndrome): MR imaging. Radiology 159:499, 1986
89. Perry TL, Hansen S, Jones K: Brain amino adds and glutathione in
progressive supranuclear palsy. Neurology 38:943, 1988
90. Pierot L, Desnos L. Blin J, et al: Dl and D2-type dopamine receptors
in patients with Parkinson's disease and progressive supranuclear
palsy. J Neurol Sci 86:291. 1988
91. Pillon B, Dubois B, Ploska A. Agid Y: Severity and specificity of
cognitive impairment Alzheimer's, Huntington's, and Parkinson's
diseases and progressive supranuclear palsy. Neurology 41:634, 1991
92. Polinsky RJ: Shy Drager Syndrome. In Jankovic J, Tolosa E, (eds):
Parkinson's Disease and Other Movement Disorders. Baltimore, Urban
& Schwarzenberg, 1988, p 121
93. Polinsky RJ. Holmes KV. Brown RT. Weise V: CSF acetylcholinesterase
levels are reduced in multiple system atrophy with autonomic failure.
Neurology 39:40, 1989
94. Quinn N: Multiple system atrophy. In Marsden CD, Fahn S (eds):
Movement Disorders 3. Butterworths, London, in press. 1992
95. Rafal RD, Posner MI. Friedman D. et al: Orienting of visual attention
in progressive supranuclear palsy. Brain 111:267, 1988
96. Rebeiz JJ. Kolodny EH, Richardson EP: Corticodentatonigral
degeneration with neuronal achromasia. Arch Neurol 18:20, 1968
97. Riley DE. Lang AE, Lewis A, et at: Cortical-basal ganglionic
degeneration. Neurology 40:1203. 1990
98. Rivest J. Quinn N. Marsden CD: Dystonia in Parkinson's disease,
multiple system atrophy. and progressive supranuclear palsy.
Neurology 40:1571. 1990
99. Saper CB. Sorrentino DM, German DC, de Lacalle S: Medullary
catecholaminergic neurons in the normal human brain and in
Parkinson's disease. Ann Neurol 29:577, 1991
100. Sawle GV. Brooks DJ. Marsden CD. Frackowiak SJ: Corticobasal
degeneration. Brain 114:541, 1991
101. Shankar SK. Yanagihara R, Garruto RM. et al: Immunocytochemical
characterization of neurofibrillary tangles in amyotrophic lateral
sclerosis and parkinsonism-dementia complex of Guam. Ann Neurol
25:146, 1989
102. Shimizu N, Takiyama Y, Mizuno Y, et al: Characteristics of
oculomotility disorders of a family with Joseph's disease.
J Neurol 237:393, 1990
103. Shy GM. Drager GA: A neurological syndrome associated with
orthostatic hypotension: A clinical-pathological study. Arch
Neurol 2:511, 1960
104. Sinatra MG. Baldini SM. Baiocco F. Carenini L: Auditory brainstem
response patterns in familial and sporadic otivopontocerebellar
atrophy. Eur Neurol 28:288. 1988
105. Snow BJ, Peppard RF, Guttman M, et al: Positron emission tomographic
scanning demonstrates a presynaptic dopaminergic lesion in Lytico-
Bodig. Arch Neurol 47:870. 1990
106. Spencer PS, Nunn PB, Hugon JS, et al; Guam amyotrophic lateral
sclerosis-parkinsonism and dementia linked to a plant excitant
neurotoxin. Science 237:517, 1987
107. Steele JC: Progressive supranuclear palsy. Brain 95:693, 1972
108. Steele JC, Richardson JC, Olszewski J: Progressive supranuclear palsy;
A heterogeneous degeneration involving the brainstem, basal ganglia
and cerebellum with vertical gaze and pseudobulbar palsy. nuchal
dystonia and dementia. Arch Neurol 2:473, 1964
109. Stern MB, Braffman BH, Skolnick BE, et al: Magnetic resonance imaging
in Parkinson's disease and parkinsonian syndromes. Neurology
39:1524, 1989
110. Tabaton M, Perry G, Autilio-Gambetti L, et al: Influence of neuronal
location on antigenic properties of neurofibrillary tangles. Ann
Neurol 23:604. 1988
111. Tomokane NT. Kitamoto T. Tateishi J, Sato Y: Immunohistochemical
quantification of substance P in spinal dorsal horns of patients
with multiple system atrophy. J Neurol Neurosurg Psych 54:535, 1991
112. Truong DD, Harding AE, Scaravilli F, et a!: Movement disorders in
mitochondrial myopathies. Mov Disorders 5:109, 1990
113. Tyrell PJ, Sawle GV, Ibanez V, et al: Clinical and positron emission
tomographic studies in the 'extrapyramidal syndrome' of dementia of
the Alzheimer type. Arch Neurol 47:1318, 1990
114. Young A: Progressive supranuclear palsy: Postmortem chemical analysis.
Ann Neurol 18:521, 1985
115. Zhang Z, Anderson DW, Lavine L, Mantel N: Patterns of acquiring
parkinsonism-dementia complex of Guam. Arch Neurol 47:1019, 1990
116. Zweig RM, Whitehouse PJ, Casanova MF, et al: loss of pedunculopontine
neurons in progressIve supranuclear palsy. Ann Neurol 22:18, 1985
Address reprint requests to
Joseph jankovic, MD
Department of Neurology
Baylor College of Medicine
6550 Fannin, 1801 Smith Tower
Houston, TX 77054
John Cottingham [log in to unmask]
